Application for approval of tecovirimat for multiple indications submitted to the European Medicines Agency

The application seeks approval for use of this small molecule antiviral for the treatment of smallpox, monkeypox, cowpox, and complications from Vaccinia infection.

Source:

Biospace Inc.